Silexion Therapeutics Corp (SLXN) insider trading

Every open-market stock purchase and sale by Silexion Therapeutics Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $31K over the last 12 months (1 sale). No open-market buys.
  • Last insider buy: Lloyd I Miller III (10% owner), $1.3K, 16 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $31K (1 sale). Last close $5.00 on Jun 7, 2026.

Recent SLXN insider trades

DateInsiderTradeValue
Jun 4, 2026Ilan Hadar (CEO)Bought (not open market)—
Jun 4, 2026Hadar Mirit Horenshtein (CFO)Bought (not open market)—
Jun 4, 2026Mitchell Shirvan (C-suite exec)Bought (not open market)—
Mar 26, 2026Mitchell Shirvan (C-suite exec)Sold$31K
Feb 20, 2026Mitchell Shirvan (C-suite exec)Bought (not open market)—
Feb 20, 2026Ilan Hadar (CEO)Bought (not open market)—
Feb 20, 2026Amnon Peled (Director)Bought (not open market)—
Feb 20, 2026Dror Yosef Abramov (Director)Bought (not open market)—
Feb 20, 2026Dror Yosef Abramov (Director)Bought (not open market)—
Feb 20, 2026Ruth Alon (Director)Bought (not open market)—
Feb 20, 2026Ruth Alon (Director)Bought (not open market)—
Feb 20, 2026Avner Lushi (Director)Bought (not open market)—
Feb 20, 2026Avner Lushi (Director)Bought (not open market)—
Feb 20, 2026Hadar Mirit Horenshtein (CFO)Bought (not open market)—
Feb 20, 2026Shlomo Noy (Director)Bought (not open market)—
Feb 20, 2026Shlomo Noy (Director)Bought (not open market)—
Feb 20, 2026Amnon Peled (Director)Bought (not open market)—

Who's trading SLXN

Get free alerts when an insider at Silexion Therapeutics Corp files a new trade →